ESR1 and neoplasm: However, the GPER-related pro-metastatic pathways identified by Maggiolini et al. were somewhat different with those in this study, maybe due to the differences of tumor subtype (ER-α negative vs. TNBC) and race of patients (mixed vs. Chinese).